Hypertrophic cardiomyopathy and membranous subaortic stenosis: a rare, but possible association

J Cardiovasc Med (Hagerstown). 2020 Feb;21(2):164-167. doi: 10.2459/JCM.0000000000000882.

Authors

Massimiliano Camilli¹, Maria C Meucci¹, Marco G Del Buono¹, Carolina Ierardi², Angelica B Delogu^{3

2}, Filippo Crea^{1

2}

Affiliations

¹ Institute of Cardiology.
² Fondazione Policlinico Universitario Agostino Gemelli, IRCCS, Rome, Italy.
³ Department of Woman and Child Health and Public Health, Catholic University of the Sacred Heart.

PMID: 31592852
DOI: 10.2459/JCM.0000000000000882

No abstract available

Publication types

Case Reports

MeSH terms

Aged
Anti-Arrhythmia Agents / therapeutic use
Antihypertensive Agents / therapeutic use
Cardiomyopathy, Hypertrophic / complications*
Cardiomyopathy, Hypertrophic / diagnostic imaging
Cardiomyopathy, Hypertrophic / drug therapy
Cardiomyopathy, Hypertrophic / physiopathology
Conservative Treatment
Discrete Subaortic Stenosis / complications*
Discrete Subaortic Stenosis / diagnostic imaging
Discrete Subaortic Stenosis / drug therapy
Discrete Subaortic Stenosis / physiopathology
Heart Defects, Congenital / complications*
Heart Defects, Congenital / diagnostic imaging
Heart Defects, Congenital / drug therapy
Heart Defects, Congenital / physiopathology
Hemodynamics* / drug effects
Humans
Male
Treatment Outcome
Ventricular Function, Left* / drug effects

Substances

Anti-Arrhythmia Agents
Antihypertensive Agents

Supplementary concepts

Subaortic Stenosis, Membranous